• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

Microdose Announces the Launch of Accredited Course Series “The Science of Psychedelics: Training for Medical Professionals”

Microdose by Microdose
March 10, 2021
in Press Releases
Reading Time: 4 mins read
A A

TORONTO, March 10, 2021 /PRNewswire/ — Microdose is pleased to announce The Science of Psychedelics: Training for Medical Professionals, an online, accredited course series for physicians, psychologists, social workers, mental health counsellors, pharmacists, and other medical professionals.

The Science of Psychedelics: Training for Medical Professionals has been approved for 8.0 AMA PRA Category 1 Credits™ through the joint providership of CME Consultants and MD Media Inc., as well as accreditation through the American Psychological Association (APA), the California Board of Registered Nursing, the California Board of Behavioral Sciences, and the Oregon Board of Naturopathic Medicine (OBNM).

The online training is available in 5 different versions:

  • 8.0 AMA PRA Category 1 Credits™for AMA-Defined Physicians (MDs, DOs)
  • 8.0 AMA PRA Category 1 Credits™for Non-AMA-Defined Physicians such as Physician Assistants (PAs), Nurse Practitioners (NPs), and Doctors of Pharmacy (PharmDs)
  • 8 Hours of Homestudy CE Credit, for Psychologists (PhDs, PsyDs), Social Workers (LicSWs), Mental Health Counselors (LMHCs), and related fields
  • 8 Continuing Education (CE) Credits for NDs, accredited through the Oregon Board of Naturopathic Medicine (OBNM)
  • Course Only, for those who do not need professional credit

Dr. Erica Zelfand, Family Physician, and the developer of the course content for The Science of Psychedelics, is happy to see her training hit a platform that’s accessible to doctors all over the world. “After teaching internationally, I am thrilled to now be able to offer my sought-after psychedelic training online. I want practitioners everywhere to have the information they need to help people in the safest, most meaningful way possible.”

[bsa_pro_ad_space id=2]
ADVERTISEMENT

To promote the launch of The Science of Psychedelics, Microdose is currently offering 15% off any version of the course for the next 7 days. You can get the discount here: https://scienceofpsychedelics.com/save15

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Here’s what you get with the course:

  • Six (6) didactic video modules of 60 to 90 minutes each, including beautiful slides, diagrams of detailed topics, and webcam of the instructor
  • Purchase Best Priced Lasix
  • Video clips and case report summaries from actual patients
  • Bibliography with cited publications and links
  • Transcriptions and keyword insights for each module
  • Links to suggested videos, articles, and other recommended resources
  • One (1) bonus module with guided self-reflection and an experiential component
  • Assessment quiz for each module
  • Evaluation form for each module (for those pursuing CE/CME)
  • Access to our online learning platform for after purchase as long as our website exists
  • Official Certificate of Completion, CE certificate, or CME certificate upon completion
  • 8 hours of CE or CME professional credit (if selected at checkout)

About CME Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CME Consultants and MD Media, Inc. CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

CME Consultants designates this enduring material for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Since AMA PRA Category 1 Credit™ is the highest form of physician credit, it can often be utilized as acceptable CE’s for professionals other than AMA-defined physicians (MDs, DOs). Other disciplines that may accept AMA PRA Category 1 Credit™ as equivalent CE or CEU for re-licensure or recertification, include, but are not limited to: Nurses (RNs), Nurse Practitioners (NPs), Physician Assistants (PAs), Doctors of Pharmacy (PharmDs), and Psychologists.

It is advisable for you to verify equivalency with your specific governing body, as state boards vary in their requirements. Some sections of this course may not be relevant to all license types. Each learner must confirm with their board if this course (or sections thereof) would be eligible for their continuing education requirements prior to enrolling in this course.

About Microdose Psychedelic Insights

Microdose Psychedelic Insights is your guide to the psychedelic industry. With a vision to shift the world’s perception of psychedelic medicine, we distribute and create the most compelling content, financial analysis, engaging events, and groundbreaking education to drive the psychedelics industry into the forefront of modern medicine.

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Microdose
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post

Mindset Pharma to Present at the Stifel GMP Conference – Psychedelics: Addressing the Global Mental Health Crisis

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.